tiprankstipranks
Trending News
More News >
Innovative Pharmaceutical Biotech Limited (HK:0399)
:0399
Hong Kong Market

Innovative Pharmaceutical Biotech (0399) Financial Statements

Compare
0 Followers

Innovative Pharmaceutical Biotech Financial Overview

Innovative Pharmaceutical Biotech's market cap is currently HK$389.99M. The company's EPS TTM is HK$-0.06; its P/E ratio is -1.59; Innovative Pharmaceutical Biotech is scheduled to report earnings on November 28, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total RevenueHK$ 2.09MHK$ 6.59MHK$ 8.07MHK$ 11.14MHK$ 15.19M
Gross ProfitHK$ 188.00KHK$ 840.00KHK$ 858.00KHK$ 1.05MHK$ 1.41M
Operating IncomeHK$ -13.26MHK$ -13.43MHK$ -20.70MHK$ -24.35MHK$ -21.34M
EBITDAHK$ -310.25MHK$ 317.75MHK$ -18.82MHK$ 228.51MHK$ -18.81M
Net IncomeHK$ -345.94MHK$ 103.40MHK$ -245.70MHK$ 296.54MHK$ -395.75M
Balance Sheet
Cash & Short-Term InvestmentsHK$ 3.70MHK$ 3.08MHK$ 1.33MHK$ 4.08MHK$ 8.99M
Total AssetsHK$ 1.09BHK$ 1.38BHK$ 1.38BHK$ 1.39BHK$ 1.40B
Total DebtHK$ 1.00BHK$ 1.01BHK$ 1.19BHK$ 941.84MHK$ 991.48M
Net DebtHK$ 999.77MHK$ 1.01BHK$ 1.19BHK$ 937.76MHK$ 982.49M
Total LiabilitiesHK$ 1.06BHK$ 1.06BHK$ 1.24BHK$ 999.73MHK$ 1.04B
Stockholders' EquityHK$ -681.19MHK$ -611.51MHK$ -795.07MHK$ -549.37MHK$ -595.35M
Cash Flow
Free Cash FlowHK$ -10.55MHK$ -8.28MHK$ -17.64MHK$ -12.34MHK$ -25.01M
Operating Cash FlowHK$ -10.55MHK$ -8.28MHK$ -17.64MHK$ -12.34MHK$ -25.01M
Investing Cash FlowHK$ 0.00HK$ 0.00HK$ 0.00HK$ -1.00KHK$ 13.00K
Financing Cash FlowHK$ 11.19MHK$ 10.32MHK$ 14.92MHK$ 7.30MHK$ 10.57M
Currency in HKD

Innovative Pharmaceutical Biotech Earnings and Revenue History

Innovative Pharmaceutical Biotech Debt to Assets

Innovative Pharmaceutical Biotech Cash Flow

Innovative Pharmaceutical Biotech Forecast EPS vs Actual EPS